| Literature DB >> 32917215 |
Laite Chen1, Lu Zhang2, Lu Shi2, Guosheng Fu1, Chenyang Jiang3.
Abstract
BACKGROUND: Postoperative atrial fibrillation (POAF) is one of the most common complications of esophagectomy, which may extend the inpatient hospital stay. Minimally invasive esophagectomy (MIE) has been increasingly used in clinical practice; however, its POAF risk and short-term mortality remain unclear. This study aimed to examine the POAF risk and in-hospital mortality rate between patients receiving MIE and open esophagectomy (OE).Entities:
Keywords: Esophageal cancer; Esophagectomy; Minimally invasive surgery; Mortality; Postoperative atrial fibrillation
Mesh:
Year: 2020 PMID: 32917215 PMCID: PMC7488674 DOI: 10.1186/s12957-020-02011-6
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Characteristics of patients undergoing open esophagectomy and minimally invasive esophagectomy (data are presented as n (%))
| Variables | Total ( | OE ( | MIE ( | |
|---|---|---|---|---|
| Demographics | ||||
| Age ≥ 60 years | 318 (66.0) | 271 (64.7) | 47 (74.6) | 0.121 |
| Sex (male) | 451 (93.6) | 391 (93.3) | 60 (95.2) | 0.784 |
| BMI ≥ 25 kg/m2 | 125 (25.9) | 106 (25.3) | 19 (30.2) | 0.412 |
| Medical history | ||||
| DM | 81 (16.8) | 63 (15.0) | 18 (28.6) | 0.007 |
| HTN | 160 (33.2) | 139 (33.2) | 21 (33.3) | 0.980 |
| Cardiac condition | ||||
| HR | 0.256 | |||
| ≤ 51 | 138 (28.6) | 115 (27.4) | 23 (36.5) | |
| < 51–74 | 119 (24.7) | 102 (24.3) | 17 (27.0) | |
| < 74–99 | 116 (24.1) | 102 (24.3) | 14 (22.2) | |
| > 99 | 109 (22.6) | 100 (23.9) | 9 (14.3) | |
| LVEF | 0.333 | |||
| ≤ 59 | 97 (26.4) | 86 (27.0) | 11 (22.0) | |
| < 59–62 | 107 (29.1) | 91 (28.6) | 16 (32.0) | |
| < 62–65 | 88 (23.9) | 72 (22.6) | 16 (32.0) | |
| > 65 | 76 (20.7) | 69 (21.7) | 7 (14.0) | |
| Medications | ||||
| β-Blocker use | 30 (6.2) | 24 (5.7) | 6 (9.5) | 0.245 |
| Diuretics use | 39 (8.1) | 33 (7.9) | 6 (9.5) | 0.655 |
| Cancer related | ||||
| Neoadjuvant therapy | 189 (39.2) | 183 (43.7) | 6 (9.5) | < 0.001 |
| Pathologic stage of cancer | 0.006 | |||
| Stage 0 | 111 (23.0) | 105 (25.1) | 6 (9.5) | |
| Stages I and II | 371 (77.0) | 314 (74.9) | 57 (90.5) | |
| Incision | < 0.001 | |||
| Ivor Lewis | 344 (71.4) | 339 (80.9) | 5 (7.9) | |
| McKeown | 134 (27.8) | 76 (18.1) | 58 (92.1) | |
| Transhiatal | 4 (0.8) | 4 (1.0) | 0 (0.0) | |
| Complications | ||||
| Pneumonia | 75 (15.6) | 64 (15.3) | 11 (17.5) | 0.655 |
| Anastomotic leak | 30 (6.2) | 22 (5.3) | 8 (12.7) | 0.023 |
| Sepsis | 78 (16.2) | 66 (15.8) | 12 (19.0) | 0.508 |
| Acute kidney injury | 169 (35.1) | 147 (35.1) | 22 (34.9) | 0.980 |
| Outcomes | ||||
| Postoperative atrial fibrillation | 53 (11.0) | 48 (11.5) | 5 (7.9) | 0.519 |
| In-hospital mortality | 17 (3.5) | 14 (3.3) | 3 (4.8) | 0.476 |
OE open esophagectomy, MIE minimally invasive esophagectomy, BMI body mass index, DM diabetes mellitus, HTN hypertension, HR heart rate, LVEF left ventricular ejection fraction
Adjusted odds ratio of postoperative atrial fibrillation
| Variables | Postoperative atrial fibrillation | ||
|---|---|---|---|
| OR | 95% CI | ||
| Procedure | |||
| MIE vs. OE | 0.185 | 0.035 | 0.039, 0.887 |
| Demographics | |||
| Age ≥ 60 vs. < 60 | 6.194 | 0.001 | 2.035, 18.849 |
| Female vs. male | 0.395 | 0.397 | 0.046, 3.398 |
| BMI: ≥ 25 vs. < 25 | 1.301 | 0.542 | 0.559, 3.028 |
| HR | |||
| < 51–74 vs. ≤ 51 | 0.637 | 0.383 | 0.232, 1.754 |
| < 74–99 vs. ≤ 51 | 0.518 | 0.238 | 0.174, 1.543 |
| > 99 vs. ≤ 51 | 1.939 | 0.178 | 0.739, 5.087 |
| LVEF (%) | |||
| < 59–62 vs. ≤ 59 | 0.442 | 0.105 | 0.165, 1.185 |
| < 62–65 vs. ≤ 59 | 0.465 | 0.135 | 0.170, 1.268 |
| > 65 vs. ≤ 59 | 0.719 | 0.506 | 0.272, 1.900 |
| Comorbidity | |||
| DM: yes vs. no | 1.977 | 0.149 | 0.783, 4.993 |
| HTN: yes vs. no | 0.603 | 0.244 | 0.258, 1.413 |
| Medication | |||
| β-Blocker use: yes vs. no | 2.157 | 0.250 | 0.582, 8.000 |
| Diuretics use: yes vs. no | 0.364 | 0.232 | 0.069, 1.911 |
| Neoadjuvant therapy: yes vs. no | 0.705 | 0.523 | 0.242, 2.059 |
| Pathologic stage of cancer | |||
| Stages I and II vs. stage 0 | 0.427 | 0.126 | 0.144, 1.269 |
| Incision | |||
| McKeown vs. Ivor Lewis | 2.742 | 0.035 | 1.075, 6.990 |
| Transhiatal vs. Ivor Lewis | 1.975 | 0.595 | 0.161, 24.259 |
OR odds ratio, CI confidence interval, OE open esophagectomy, MIE minimally invasive esophagectomy, BMI body mass index, DM diabetes mellitus, HTN hypertension, HR heart rate, LVEF left ventricular ejection fraction
Adjusted odds ratio of in-hospital mortality
| Variables | In-hospital mortality | ||
|---|---|---|---|
| OR | 95% CI | ||
| Procedure | |||
| MIE vs. OE | 0.709 | 0.712 | 0.114, 4.409 |
| Demographics | |||
| Age: ≥ 60 vs. < 60 | 0.773 | 0.713 | 0.196, 3.048 |
| Female vs. male | 5.140 | 0.145 | 0.570, 46.341 |
| BMI: ≥ 25 vs. < 25 | 0.246 | 0.159 | 0.035, 1.731 |
| Comorbidity | |||
| DM: yes vs. no | 1.596 | 0.573 | 0.314, 8.113 |
| HTN: yes vs. no | 0.430 | 0.314 | 0.083, 2.225 |
| Medication | |||
| β-Blocker use: yes vs. no | 8.457 | 0.118 | 0.582, 122.884 |
| Diuretics use: yes vs. no | 1.142 | 0.942 | 0.032, 40.809 |
| Neoadjuvant therapy: yes vs. no | 0.381 | 0.303 | 0.061, 2.391 |
| Pathologic stage of cancer | |||
| Stages I and II vs. stage 0 | 0.239 | 0.147 | 0.034, 1.655 |
| Incision | |||
| McKeown vs. Ivor Lewis | 2.091 | 0.300 | 0.519, 8.425 |
| Transhiatal vs. Ivor Lewis | 76.196 | 0.013 | 2.537, 2288.307 |
| Complication | |||
| Pneumonia: yes vs. no | 48.763 | 0.003 | 3.716, 639.874 |
| Anastomotic leak: yes vs. no | 2.299 | 0.288 | 0.496, 10.661 |
| Sepsis: yes vs. no | 1.451 | 0.742 | 0.158, 13.322 |
| Acute kidney injury: yes vs. no | 1.663 | 0.427 | 0.474, 5.841 |
OR odds ratio, CI confidence interval, OE open esophagectomy, MIE minimally invasive esophagectomy, BMI body mass index, DM diabetes mellitus, HTN hypertension